Published in J Virol on March 01, 1998
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev (2003) 2.68
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol (1999) 2.34
Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol (2002) 1.97
Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol (1998) 1.95
Measles virus assembly within membrane rafts. J Virol (2000) 1.65
Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol (2001) 1.47
Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A (2003) 1.41
Glycoprotein interactions in paramyxovirus fusion. Future Virol (2009) 1.36
Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J (2000) 1.33
A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol (2003) 1.28
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J Virol (2006) 1.20
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Attenuated measles virus as a vaccine vector. Vaccine (2007) 1.13
Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions. Proc Natl Acad Sci U S A (2011) 1.13
Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. J Virol (2000) 1.11
Measles virus. Hum Vaccin Immunother (2014) 1.09
Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses. J Virol (2002) 1.08
Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein. J Virol (2003) 1.05
DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells. PLoS Pathog (2011) 1.00
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J Virol (2000) 0.98
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. J Virol (1999) 0.97
Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins. J Virol (2001) 0.93
Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster. J Virol (2012) 0.92
Cell-cell fusion induced by measles virus amplifies the type I interferon response. J Virol (2007) 0.92
Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89
Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol (2004) 0.88
Applications and challenges of multivalent recombinant vaccines. Hum Vaccin Immunother (2012) 0.84
A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus. J Virol (2005) 0.82
Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization. J Virol (2011) 0.82
F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin. J Virol (2012) 0.81
Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression. J Virol Methods (2009) 0.80
Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum Vaccin Immunother (2013) 0.80
Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins. Cancer Gene Ther (2013) 0.79
Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts. J Virol (2009) 0.77
Dimerization Efficiency of Canine Distemper Virus Matrix Protein Regulates Membrane Budding Activity. J Virol (2017) 0.75
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A (1994) 4.86
Budding of rabies virus particles in the absence of the spike glycoprotein. Cell (1996) 4.46
The budding mechanisms of enveloped animal viruses. J Gen Virol (1980) 4.08
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81
Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A (1996) 3.54
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J Virol (1993) 2.54
Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol (1993) 2.38
Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell (1994) 2.08
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol (1990) 2.05
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity. Nucleic Acids Res (1992) 1.86
Basis for selective incorporation of glycoproteins into the influenza virus envelope. J Virol (1993) 1.84
The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol (1996) 1.83
A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J Virol (1992) 1.80
Highly stable expression of a foreign gene from rabies virus vectors. Proc Natl Acad Sci U S A (1996) 1.72
Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein. Proc Natl Acad Sci U S A (1996) 1.71
Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells. J Virol (1981) 1.52
Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J Virol (1991) 1.41
Immunological relationships between homologous structural polypeptides of measles and canine distemper virus. J Gen Virol (1980) 1.40
Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology (1992) 1.39
Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin. J Virol (1992) 1.37
Measles virus: conditions for the propagation and purification of infectious virus in high yield. J Virol Methods (1984) 1.35
The molecular length of measles virus RNA and the structural organization of measles nucleocapsids. J Gen Virol (1984) 1.33
Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol (1995) 1.32
Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. Acta Virol (1972) 1.30
Viral pseudotypes and phenotypic mixing. Arch Virol (1976) 1.26
T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell Immunol (1996) 1.23
Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion. Virology (1996) 1.13
Pseudotypes of vesicular stomatitis virus with the envelope properties of mammalian and primate retroviruses. J Virol (1977) 1.12
Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein. J Gen Virol (1995) 1.12
Phenotypic mixing between group A arboviruses. Nature (1966) 1.10
Appendix: measles virus antigenome and protein consensus sequences. Curr Top Microbiol Immunol (1995) 1.06
Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence. J Virol (1992) 1.03
Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J Virol (1996) 0.98
Efficient multiplication of a Semliki Forest virus chimera containing Sindbis virus spikes. J Virol (1997) 0.93
Expression of additional genes in a vector derived from a minimal RNA virus. Virology (1996) 0.90
Subcellular localization of the sulphation reaction of heparan sulphate synthesis and transport of the proteoglycan to the cell surface in rat liver. Biochem J (1988) 0.83
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
The nucleotide sequence complexity of avian tumor virus RNA. Proc Natl Acad Sci U S A (1974) 4.86
Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J Cell Biol (1988) 4.81
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
Control of early viral and bacterial distribution and disease by natural antibodies. Science (1999) 4.73
A physical map of the Rous sarcoma virus genome. J Mol Biol (1976) 4.56
Replication strategy of human hepatitis B virus. J Virol (1987) 4.42
Mapping of biological functions on RNA of avian tumor viruses: location of regions required for transformation and determination of host range. Proc Natl Acad Sci U S A (1975) 4.01
Use of polymerase chain reaction for detection of Chlamydia trachomatis. J Clin Microbiol (1990) 3.83
Electron microscope visualization of chromatin and other DNA-protein complexes. Annu Rev Biophys Bioeng (1978) 3.73
Involvement of N-acyl-L-hormoserine lactone autoinducers in controlling the multicellular behaviour of Serratia liquefaciens. Mol Microbiol (1996) 3.71
Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol Gen Genet (1987) 3.59
Elevation of troponin I in sepsis and septic shock. Intensive Care Med (2001) 3.47
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Measles virus editing provides an additional cysteine-rich protein. Cell (1989) 3.22
Localization of Q-beta maturation cistron ribosome binding site. Nat New Biol (1971) 2.91
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop Relat Res (1989) 2.71
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Endotracheal tube introducer for failed intubations: a variant of the gum elastic bougie. Ann Emerg Med (2000) 2.65
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication. Cell (1977) 2.55
Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell (1989) 2.54
Structure and function of phage RNA. Annu Rev Biochem (1973) 2.50
Characterization of components released by alkali disruption of simian virus 40. J Virol (1977) 2.48
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Replication of viral ribonucleic acid. IX. Properties of double-stranded RNA from Escherichia coli infected with bacteriophage MS2. J Mol Biol (1966) 2.45
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol (1999) 2.34
Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod (2001) 2.24
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology (1995) 2.11
Differentiation of Serratia liquefaciens into swarm cells is controlled by the expression of the flhD master operon. J Bacteriol (1996) 2.08
Monoclonal antibodies localize events in the folding, assembly, and intracellular transport of the influenza virus hemagglutinin glycoprotein. Cell (1988) 2.07
Induction of phospholipase- and flagellar synthesis in Serratia liquefaciens is controlled by expression of the flagellar master operon flhD. Mol Microbiol (1995) 2.07
Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology (1997) 2.01
Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region. Virology (1995) 1.96
Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide". J Biol Chem (1989) 1.96
The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology (1996) 1.95
Morphogenesis of influenza A virus in Ehrlich ascites tumor cells as revealed by thin-sectioning and freeze-etching. J Virol (1969) 1.92
Mutations in the middle of the transmembrane domain reverse the polarity of transport of the influenza virus hemagglutinin in MDCK epithelial cells. J Cell Biol (1998) 1.89
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
The fimD gene required for cell surface localization of Escherichia coli type 1 fimbriae. Mol Gen Genet (1990) 1.89
The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol (2001) 1.88
Circular, repetitive DNA in yeast. Biochim Biophys Acta (1972) 1.88
Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J Biol Chem (2001) 1.87
Sequence of the first 175 nucleotides from the 5' terminus of Qbeta RNA synthesized in vitro. Nature (1969) 1.84
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol (1988) 1.84
Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood (2001) 1.84
Salt and divalent cations affect the flexible nature of the natural beaded chromatin structure. Nucleic Acids Res (1977) 1.83
A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res (1985) 1.82
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood (2001) 1.82
Retracted Functional and nonfunctional measles virus matrix genes from lethal human brain infections. J Virol (1991) 1.82
Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology (1989) 1.82
Studies on the structure and synthesis of Rous sarcoma virus RNA. Cold Spring Harb Symp Quant Biol (1975) 1.80
Expression of hepatitis B antigens with a simian virus 40 vector. J Virol (1984) 1.80
Initiation sites of Rous sarcoma virus RNA-directed DNA synthesis in vitro. Nature (1976) 1.77
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Physical and genetic mapping of the genomes of five Mycoplasma hominis strains by pulsed-field gel electrophoresis. J Bacteriol (1992) 1.74
Fusion of erythrocytes by Sendai virus studied by immuno-freeze-etching. J Virol (1973) 1.71
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70
Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results. Clin Exp Rheumatol (2004) 1.68
Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant (2001) 1.67
Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. J Cell Sci (1993) 1.66
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol (1998) 1.62
V and C proteins of measles virus function as virulence factors in vivo. Virology (2000) 1.61
Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol (1993) 1.60
Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection. Mol Microbiol (1997) 1.58
Detection of an element of the SV40 late promoter in vectors used for expression studies in COS cells. EMBO J (1983) 1.57
Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis. Eur J Immunol (1991) 1.55
Altered ratios of measles virus transcripts in diseased human brains. Virology (1987) 1.55
Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 1.51
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Molecular basis for repressor activity of Q replicase. Nat New Biol (1972) 1.49
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
Morphogenesis and ultrastructure of respiratory syncytial virus. J Virol (1973) 1.48
HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum (1988) 1.48